Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
PTC Therapeutics (PTCT)
NASDAQ:PTCT
Holding PTCT?
Track your performance easily
PTC Therapeutics (PTCT) Ownership Overview
1.15% Insiders
30.05% Mutual Funds
38.69% Other Institutional Investors
17.50% ETFs
12.62% Public Companies and
Individual Investors
The ownership structure of PTC Therapeutics (PTCT) stock is a mix of institutional, retail, and individual investors. Approximately 86.23% of the company’s stock is owned by Institutional Investors, 1.15% is owned by Insiders, and 12.62% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 18, 2024 | xxxxxxxxxxxxx | $77191 | |
| May 24, 2024 | Jerome Zeldis Director | xxxxxxxxxxxxx | $764800 |
| May 08, 2024 | Lee Scott Golden Evp & Chief Medical Officer | xxxxxxxxxxxxx | $5744 |
| Apr 22, 2024 | Matthew B. Klein Ceo,director | xxxxxxxxxxxxx | $83655 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,284,076 | Institution | 9.44% | 285,754,301 | |
| 6,556,813 | Institution | 8.50% | 257,223,774 | |
| 4,168,888 | Institution | 5.41% | 163,545,476 | |
| 3,815,844 | Institution | 4.95% | 149,695,560 | |
| 1,800,499 | Institution | 2.33% | 70,633,576 | |
| 1,382,679 | Institution | 1.79% | 54,242,497 | |
| 1,304,756 | Institution | 1.69% | 51,185,578 | |
| 1,095,290 | Institution | 1.42% | 42,968,227 | |
| 874,188 | Institution | 1.13% | 34,294,395 | |
| 855,911 | Institution | 1.11% | 33,577,389 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,556,813 | Institution | 8.50% | 257,223,774 | |
| 4,168,888 | Institution | 5.41% | 163,545,476 | |
| 1,800,499 | Institution | 2.33% | 70,633,576 | |
| 1,382,679 | Institution | 1.79% | 54,242,497 | |
| 874,188 | Institution | 1.13% | 34,294,395 | |
| 855,911 | Institution | 1.11% | 33,577,389 | |
| 852,706 | Institution | 1.11% | 33,451,656 | |
| 823,985 | Institution | 1.07% | 32,324,932 | |
| 808,269 | Institution | 1.05% | 31,708,393 | |
| 540,788 | Institution | 0.70% | 21,215,113 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,414,982 | Institution | 3.13% | 89,595,832 | |
| 2,147,575 | Institution | 2.78% | 84,249,367 | |
| 1,924,351 | Institution | 2.50% | 71,393,422 | |
| 1,164,683 | Institution | 1.51% | 49,359,266 | |
| 1,151,849 | Institution | 1.49% | 42,733,598 | |
| 1,061,863 | Institution | 1.38% | 39,395,117 | |
| 521,969 | Institution | 0.68% | 20,476,844 | |
| 511,935 | Institution | 0.66% | 20,083,210 | |
| 371,821 | Institution | 0.48% | 15,757,774 | |
| 349,248 | Institution | 0.45% | 12,957,101 |
FAQ
Who Owns PTC Therapeutics (PTCT)?
According to the latest TipRanks data, approximately 38.69% of the company's stock is held by institutional investors, 1.15% is held by insiders, and 12.62% is held by retail investors.
What percentage of PTC Therapeutics (PTCT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.69% of PTC Therapeutics (PTCT) stock is held by institutional investors.
What percentage of PTC Therapeutics (PTCT) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.62% of PTC Therapeutics (PTCT) stock is held by retail investors.
Who owns the most shares of PTC Therapeutics (PTCT)?
Vanguard owns the most shares of PTC Therapeutics (PTCT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.